Stock Events

Stock Events

Devonian Health Group 

$4.80
1
+$0.00+0%Tuesday 20:56

Statistics

Day High
4.8
Day Low
4.8
52W High
10.65
52W Low
4.27
Volume
400
Avg. Volume
68
Mkt Cap
13.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Dec 22Expected
Q3 2022
-0.01
0.33
0.66
0.99
Expected EPS
N/A
Actual EPS
-0.0069

Financials

-25.94%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
16.72MRevenue
-4.34MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap81.62M
Corbus Pharmaceuticals develops innovative therapeutics in the area of inflammatory and fibrotic diseases, overlapping with Devonian's therapeutic areas.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.55B
Acadia Pharmaceuticals specializes in biopharmaceuticals for central nervous system disorders, a field relevant to Devonian's product development.
Supernus
SUPN
Mkt Cap2.44B
Supernus Pharmaceuticals focuses on CNS diseases, directly competing with Devonian's therapeutic focus.
Alnylam Pharmaceuticals
ALNY
Mkt Cap22.1B
Alnylam Pharmaceuticals works on RNAi therapeutics, competing in the innovative pharmaceuticals space with Devonian.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals engages in creating new drugs for serious diseases, similar to Devonian's mission in botanical-based therapeutics.
Incyte
INCY
Mkt Cap24.54B
Incyte specializes in oncology and inflammatory diseases, areas that Devonian might target with its botanical drugs.
AMGEN
AMGN
Mkt Cap251.94B
Amgen, a biotech giant, competes broadly in the pharmaceuticals market, including areas that might overlap with Devonian's botanical treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals is involved in biopharmaceuticals for a variety of therapeutic areas, potentially competing with Devonian's products.

About

Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The firm is engaged in the development of drugs for a range of autoimmune and fibroinflammatory conditions, using novel therapeutic approaches to address unmet medical needs. It offers therapeutic and cosmeceutical products. Its drug candidate, Thykamine product is issued from Devonian’s SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune disorders. The company was founded by Andre P. Boulet on March 27, 2015 and is headquartered in Montmagny, Canada.
Show More
CEO
André Boulet
Employees
11
Country
Canada
ISIN
CA2518348834

Listings

OTC Link
US
DVHGF
V
CA
GSD.V

0 Comments

Share your thoughts

FAQs

What is Devonian Health Group stock price today?▼
The current price of DVHGF is $4.80 USD — it has increased by +0% in the past 24 hours. Watch Devonian Health Group stock price performance more closely on the chart.
What is Devonian Health Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Devonian Health Group stocks are traded under the ticker DVHGF.
What is Devonian Health Group market cap?▼
Today Devonian Health Group has the market capitalization of 13.34M
What were Devonian Health Group earnings last quarter?▼
DVHGF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Devonian Health Group revenue for the last year?▼
Devonian Health Group revenue for the last year amounts to 16.72M USD.
What is Devonian Health Group net income for the last year?▼
DVHGF net income for the last year is -4.34M USD.
How many employees does Devonian Health Group have?▼
As of November 5, 2026, the company has 11 employees.
In which sector is Devonian Health Group located?▼
Devonian Health Group operates in the Health & Wellness sector.
When did Devonian Health Group complete a stock split?▼
The last stock split for Devonian Health Group was on January 22, 2026 with a ratio of 1:60.
Where is Devonian Health Group headquartered?▼
Devonian Health Group is headquartered in Montmagny, Canada.